Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog SafiledCriticalGlaxosmithkline Biolog Sa
Publication of ECSP034474ApublicationCriticalpatent/ECSP034474A/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
Este invento se refiere a un procedimiento para la producción de un antigeno de la hepatitis B adecuado para uso en una vacuna, comprendiendo el procedimiento la purificación del antigeno en presencia de cisteína y a vacunas que comprenden tales antígenos.This invention relates to a process for the production of a hepatitis B antigen suitable for use in a vaccine, the method comprising the purification of the antigen in the presence of cysteine and to vaccines comprising such antigens.
COMPOSITION COADYUVANTE, COMPOSITIONS OF VACCINES THAT INCLUDE SUCH COMPOSITION COADYUVANTE; PROCEDURE FOR INDUCTION OF IMMUNE IMMUNORESPUESTAS AMMAMIFEROS AND PROCEDURE OF TREATMENT WHERE SUCH VACCINES APPLY